OTLC · Oncotelic Therapeutics, Inc.

Substantial doubt about the company's ability to continue as a going concern.

“The Company's limited capital resources, history of recurring losses and uncertainties as to whether the Company's operations will become profitable raise substantial doubt about its ability to continue as a going concern.”